placebo + insulin

This is a combination of a placebo (an inert substance with no pharmacological activity) and insulin (a peptide hormone used therapeutically to lower blood glucose). In clinical research, "placebo + insulin" typically refers to the use of both an inactive control (placebo) and active drug (insulin) in parallel or as part of a crossover design to assess the effects of insulin compared to no active treatment. Placebos are used as controls in trials to distinguish the true pharmacological effect of insulin from psychological or other non-specific effects. Insulin acts by binding to the insulin receptor, promoting cellular uptake of glucose, and regulating carbohydrate, fat, and protein metabolism. The combination itself does not represent a marketed pharmaceutical product but rather describes an experimental setup for clinical studies[1][4][5].